The World Health Organization (WHO) has officially responded to a formal notification of withdrawal from the United States, expressing profound regret over a decision that the agency warns will leave both the American public and the global community more vulnerable to health crises. In a comprehensive statement issued from its Geneva headquarters, the WHO defended its historical record and its response to the COVID-19 pandemic while directly addressing accusations from Washington regarding its independence and operational integrity. This move marks a significant fracture in the international public health architecture, as the United States has served as a foundational pillar and the largest financial contributor to the organization since its inception in 1948.
The notification of withdrawal, which sets in motion a complex legal and administrative process, will be a primary focus of the WHO Executive Board during its regular meeting scheduled for February 2. The implications of the American departure are expected to be further deliberated during the World Health Assembly in May 2026. As the international community grapples with the potential loss of its most influential member state, the WHO has reiterated its commitment to global health equity, even as it prepares for a future that may lack direct U.S. participation.
A Legacy of Cooperation and Achievement
The relationship between the United States and the WHO has historically been one of deep integration and mutual benefit. As a founding member, the U.S. was instrumental in drafting the WHO Constitution, which posits that the "enjoyment of the highest attainable standard of health is one of the fundamental rights of every human being." Over the past seven decades, this partnership has yielded some of the most significant triumphs in the history of medicine and public health.
Most notably, U.S. technical expertise and financial resources were pivotal in the global campaign to eradicate smallpox, a feat achieved in 1980. Furthermore, the collaboration has brought the world to the brink of eradicating polio and has made substantial inroads against HIV/AIDS through programs like PEPFAR, which works in close coordination with WHO standards. The U.S. Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH) have traditionally operated as key WHO collaborating centers, providing the scientific backbone for global responses to influenza, Ebola, tuberculosis, and malaria.
The WHO’s statement emphasized that U.S. contributions have been essential in addressing neglected tropical diseases, improving food safety standards, and combating the rising threat of antimicrobial resistance. The agency noted that the systems developed to monitor these threats operate 24/7, providing a global safety net that has historically protected American citizens by identifying and neutralizing pathogens at their source before they reach U.S. shores.
Addressing Allegations of Mismanagement and Bias
The decision to withdraw appears rooted in a series of sharp criticisms leveled by the U.S. government. Statements from Washington have alleged that the WHO "trashed and tarnished" the United States, insulted its leadership, and allowed its institutional independence to be compromised by nations hostile to American interests. The U.S. government has characterized the WHO as a "politicized, bureaucratic" entity that failed in its core mission during the COVID-19 pandemic.
In its rebuttal, the WHO categorically denied these claims. "The reverse is true," the organization stated, asserting that it has always sought to engage with the United States in good faith and with full respect for U.S. sovereignty. The agency pushed back against the notion that it is driven by a hidden agenda, noting that as a specialized agency of the United Nations, it is governed by 194 Member States and remains impartial.
A central point of contention remains the WHO’s handling of the COVID-19 crisis. The U.S. government has accused the agency of "obstructing the timely and accurate sharing of critical information" and "concealing failures" to protect the interests of China. The WHO, while acknowledging that no organization or government achieved a perfect response to the unprecedented crisis, stood firmly by its actions. The agency clarified that while it recommended public health measures such as masking and physical distancing, it never issued mandates for vaccines or lockdowns, emphasizing that such decisions remain the sole prerogative of sovereign governments.
Chronology of the COVID-19 Response
To counter claims of delayed action, the WHO provided a detailed timeline of its activities during the early weeks of the pandemic. This chronology is intended to demonstrate a rapid and transparent escalation of the global alarm system:
- December 31, 2019: The WHO’s Country Office in China picked up a media statement by the Wuhan Municipal Health Commission regarding cases of ‘viral pneumonia.’ The WHO immediately requested more information from Chinese authorities and activated its emergency incident management system.
- January 1, 2020: The WHO requested information on the cluster of cases from the Chinese authorities under the International Health Regulations (IHR).
- January 10-12, 2020: WHO published a comprehensive package of guidance for countries on how to detect, test, and manage potential cases. China shared the genetic sequence of COVID-19 on January 12, which was critical for the development of diagnostic kits.
- January 30, 2020: The WHO Director-General declared the outbreak a Public Health Emergency of International Concern (PHEIC)—the highest level of alarm under international law. At this time, there were fewer than 100 cases and zero deaths outside of China.
- February 2020: The Director-General warned that the "window of opportunity" to contain the virus was closing and famously stated that "this is not a drill."
- March 11, 2020: COVID-19 was officially characterized as a pandemic.
The WHO argues that this timeline proves it acted with urgency based on the evidence available at the time. The organization noted that it consistently urged countries to take immediate action to protect their populations long before the virus reached critical levels in the West.
Financial and Operational Data: The Impact of U.S. Withdrawal
The departure of the United States presents a significant financial challenge to the WHO. Historically, the U.S. has been the largest contributor to the organization’s biennial budget. For the 2022-2023 funding cycle, the U.S. contribution exceeded $700 million when combining assessed contributions (membership dues) and voluntary contributions (funding for specific programs).
Data from the WHO’s financial reports indicate that U.S. funding is particularly vital for:
- Polio Eradication: The U.S. provides a large portion of the budget for the Global Polio Eradication Initiative.
- Emergency Operations: U.S. funds often support rapid response teams in conflict zones and areas hit by natural disasters.
- Vaccine Research and Distribution: The U.S. has been a key player in the COVAX pillar, aimed at ensuring equitable vaccine access.
Beyond the financial loss, the "brain drain" of American scientists and experts from WHO technical committees could slow the development of international health standards. The WHO currently relies on thousands of American experts who serve on various advisory groups, providing expertise on everything from cancer research to the classification of diseases.
Global Reactions and Political Context
The international community has reacted with concern to the U.S. notification. Leaders from the European Union and various G7 nations have previously urged the United States to reconsider, arguing that global health threats require global cooperation. Public health experts from institutions such as the Lancet and the Johns Hopkins Bloomberg School of Public Health have warned that a U.S. withdrawal could lead to a "fragmented and weakened" global health landscape, potentially allowing new diseases to spread unchecked.
Conversely, some critics within the U.S. political sphere have supported the withdrawal, arguing that the WHO requires fundamental structural reform that can only be prompted by a radical break. They point to the need for greater transparency in how the agency interacts with powerful member states and call for a more rigorous audit of its spending and decision-making processes.
Broader Implications and the Future of International Health Law
The U.S. withdrawal comes at a time when the WHO is attempting to modernize international health law. Last year, Member States adopted the WHO Pandemic Agreement, a landmark instrument designed to prevent a repeat of the COVID-19 catastrophe. Currently, nations are negotiating an annex to this agreement—the Pathogen Access and Benefit Sharing (PABS) system. This system is intended to ensure that when a new pathogen is detected, it is shared rapidly with the world in exchange for equitable access to the resulting vaccines and treatments.
The absence of the United States, a world leader in pharmaceutical innovation, could significantly hamper the effectiveness of the PABS system. Without U.S. participation, the agreement may lack the necessary leverage to ensure that the private sector complies with global equity goals.
Despite the looming departure, the WHO remains steadfast. "WHO remains steadfastly committed to working with all countries in pursuit of its core mission," the statement concluded. The agency expressed hope that the United States would eventually return to active participation, echoing the sentiment that the "highest attainable standard of health" is a goal that transcends national borders and political disputes. For now, the global health community must prepare for a transition period that will test the resilience of international cooperation in an increasingly polarized world.